- In late February 2026, Resideo Technologies reported fourth-quarter 2025 results showing sales of US$1,895 million and net income of US$136 million, alongside full-year 2025 sales of US$7.47 billion and a full-year net loss of US$527 million.
- At the same time, management issued 2026 revenue guidance of US$7.80–US$7.90 billion, signaling confidence in ongoing initiatives such as operational improvements, product innovation, and the planned ADI Global Distribution spin-off.
- We’ll now examine how Resideo’s confident 2026 revenue outlook and improving quarterly profitability may influence the existing investment narrative.
Invest in the nuclear renaissance through our list of 84 elite nuclear energy infrastructure plays powering the global AI revolution.
Resideo Technologies Investment Narrative Recap
To own Resideo today, you need to believe it can turn record revenue into consistent profitability while reshaping itself through the ADI spin-off. The latest results show solid Q4 earnings but a full-year net loss, so the near-term catalyst is whether 2026 execution matches the higher revenue outlook. The biggest risk remains that competition and ongoing losses keep pressuring margins. The new guidance does not remove that risk, but it gives management less room for missteps.
The most relevant update here is the new 2026 revenue guidance of US$7.80–US$7.90 billion, which sits above 2025’s US$7.47 billion. That outlook ties directly to Resideo’s push to improve operations, refresh products, and prepare ADI Global Distribution for separation. How effectively the company delivers on this guidance will shape whether the spin-off becomes a value-creating catalyst or simply exposes the underlying margin and execution challenges more clearly.
Yet behind the upbeat 2026 outlook, investors should also be aware of the risk that...
Read the full narrative on Resideo Technologies (it's free!)
Resideo Technologies' narrative projects $8.0 billion revenue and $597.5 million earnings by 2028. This requires 2.6% yearly revenue growth and a $1,413.5 million earnings increase from $-816.0 million today.
Uncover how Resideo Technologies' forecasts yield a $45.00 fair value, a 16% upside to its current price.
Exploring Other Perspectives
Some of the most optimistic analysts were already assuming revenue around US$7.9 billion and a swing to roughly US$441 million in earnings, so this upbeat 2026 guidance could either support their view of margin improvement or force a rethink if execution or the ADI spin-off stumbles, reminding you that reasonable investors can look at the same numbers and reach very different conclusions.
Explore 2 other fair value estimates on Resideo Technologies - why the stock might be worth as much as 16% more than the current price!
The Verdict Is Yours
Don't just follow the ticker - dig into the data and build a conviction that's truly your own.
- A great starting point for your Resideo Technologies research is our analysis highlighting 3 key rewards and 1 important warning sign that could impact your investment decision.
- Our free Resideo Technologies research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Resideo Technologies' overall financial health at a glance.
Want Some Alternatives?
Opportunities like this don't last. These are today's most promising picks. Check them out now:
- AI is about to change healthcare. These 27 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
- The future of work is here. Discover the 30 top robotics and automation stocks leading the charge in AI-driven automation and industrial transformation.
- Explore 22 top quantum computing companies leading the revolution in next-gen technology and shaping the future with breakthroughs in quantum algorithms, superconducting qubits, and cutting-edge research.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com